OneSkin
San Francisco, US · Founded 2016 · Delaware corporation · 8 known investors
Find your way into OneSkin
Sign up to see every warm intro you have to OneSkin
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OneSkin team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
OneSkin develops skincare products based on its OS-01 Peptide, an ingredient the company says targets cellular senescence to address signs of skin aging. Founded by scientists, it positions its products within the longevity and skin-health consumer market.
Founders & leadership




Board
Investors · 8
How we know: the VCSheet dataset · Not right? Tell us
How we know: Metaplanet's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · beautyindependent.com · the VCSheet dataset · Not right? Tell us
How we know: funding news · indiebio.co · open dataset · 5k.vc investor directory · sosv.com · Not right? Tell us
How we know: Unilever Ventures's portfolio page · funding news · beautyindependent.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$40.4M disclosed across 4 rounds · 2017–2025
▶$20.4MraisedJun 2025 · 1 investors · BiotechnologyRule 506(b)
- Carolina Reis de OliveiraExecutive Officer, Director
- Alessandra ZonariDirector
- Tara PoseleyDirector
- Offering amount
- $20.4M
- Amount sold
- $20.4M
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedOct 2024 · 11 investors · BiotechnologyRule 506(b)
- Carolina Reis de OliveiraExecutive Officer, Director
- Alessandra ZonariDirector
- Tara PoseleyDirector
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.4MraisedOct 2022 · 19 investors · BiotechnologyRule 506(b)
- Carolina Reis de OliveiraExecutive Officer, Director
- Offering amount
- $12.4M
- Amount sold
- $12.4M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$626.6KraisedApr 2017 · 3 investors · BiotechnologyRule 506(b)
- Edgar Andres Ochoa CruzExecutive Officer, Director
- Carolina Reis de OliveiraExecutive Officer, Director
- Offering amount
- $2.4M
- Amount sold
- $626.6K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Companies working in the same space as OneSkin.
In the news
Frequently asked questions
- What does OneSkin do?
- OneSkin develops skincare products based on its OS-01 Peptide, an ingredient the company says targets cellular senescence to address signs of skin aging. Founded by scientists, it positions its products within the longevity and skin-health consumer market.
- Who founded OneSkin?
- OneSkin was founded by Carolina Reis de Oliveira, Alessandra Zonari, Carolina Reis Oliveira, Alessandra Zonari Scheel, Mariana Boroni, PhD, Juliana Carvalho, PhD in 2016.
- Who are OneSkin's investors?
- OneSkin's investors include Able Partners, Metaplanet, PHD Ventures, PLUS Capital, Selva Ventures, SOSV, Unilever Ventures, Prelude Growth Partners.
- How much funding has OneSkin raised?
- OneSkin has disclosed $40.4M raised across 4 rounds.
- Where is OneSkin headquartered?
- OneSkin is headquartered in San Francisco, US.




